Future studies should also account for potential confounding factors affecting the association between TLR4 and schizophrenia, such as TLR4 gene polymorphisms, AP medication type, duration and dosage, duration of disease, and different phases of schizophrenia (prodromal, active, residual). The gene discussed is TLR4; the disease is schizophrenia.